Nationwide Fund Advisors’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Nationwide Fund Advisors’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,500	Closed	-$90K	–	3409
2014 Q4	$90K	Buy	6,500 +2,212	+52%	+$31.6K	﹤0.01%	2935
2014 Q3	$53K	Hold	4,288	–	–	﹤0.01%	3095
2014 Q2	$78K	Sell	4,288 -1,116	-21%	-$19.1K	﹤0.01%	3063
2014 Q1	$117K	Buy	5,404 +4,340	+408%	+$126K	﹤0.01%	2706
2013 Q4	$38K	Buy	1,064 +162	+18%	+$5.43K	﹤0.01%	3083
2013 Q3	$33K	Buy	902 +98	+12%	+$4.46K	﹤0.01%	3069
2013 Q2	$36K	Buy	+804	New	+$36.5K	﹤0.01%	3022

Other funds holding KBIO

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nationwide Fund Advisors's KBIO Position: Q1 2015 in Review

Nationwide Fund Advisors sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 6,500 shares — an estimated $90K sold.

Nationwide Fund Advisors first reported a position in KBIO in Q2 2013 and held it in 7 quarters. The position peaked at $117K in Q1 2014. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

Nationwide Fund Advisors reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
Nationwide Fund Advisors sold 6,500 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $90K.
Nationwide Fund Advisors first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 7 quarters.
Nationwide Fund Advisors's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $117K in Q1 2014.
24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on Nationwide Fund Advisors's 13F filing for Q1 2015, filed 5 May 2015.